A new study carried out by the scientists at the Krembil Brain Institute in Canada revealed that drinking coffee might lower risks of Alzheimer’s and Parkinson’s diseases thanks to this beverage’s phenylindanes substances that form during the coffee roasting process, which seem to be beneficial for the human brain.
According to the researchers, phenylindanes forbid the binding of amyloid-beta and tau proteins which are both in the brains of those with Alzheimer’s and Parkinson’s diseases. As Dr. Ross Mancini, who took part in the investigation, these discoveries are significant for improving the methods used for the prevention of these neurodegenerative diseases.
“It’s the first time anybody’s investigated how phenylindanes interact with the proteins that are responsible for Alzheimer’s and Parkinson’s,” said Dr. Mancini. The next step would be to investigate how beneficial these compounds are, and whether they have the ability to enter the bloodstream or cross the blood-brain barrier,” he added.
Drinking Coffee Might Lower Risks of Alzheimer’s and Parkinson’s Diseases
Mother Nature is a much better chemist than we are and Mother Nature is able to make these compounds. What this study does is take the epidemiological evidence and try to refine it and to demonstrate that there are indeed components within coffee that are beneficial to ward off cognitive decline,” also said Dr. Donald Weaver, co-director of the Krembil Brain Institute in Canada.
As for the brand of coffee they used in their examination, the scientists made their clinical trial with Starbucks brand 100 percent Arabica instant coffee. They also found out that the dark roasted coffee is better in protecting the brain from Alzheimer’s and Parkinson’s diseases, but the other types of coffee have also yielded positive results.
“It’s interesting but are we suggesting that coffee is a cure? Absolutely not,” concluded Dr. Weaver who also said that further studies are needed to verify the effects of coffee against Alzheimer’s and Parkinson’s diseases.